A recurring report in supplement forums is that periods got noticeably heavier after starting nattokinase. Given what nattokinase does, that is mechanistically plausible. It is also, surprisingly, completely unstudied. Here is how to think about it, and why the more important question is what else heavy bleeding could mean.
Key Takeaways
- There are no clinical studies evaluating nattokinase’s effects on menstrual bleeding. Everything here is mechanism and clinical caution, not trial data.
- The mechanism is plausible. Menstruation is regulated in part by local fibrinolysis in the endometrium, and nattokinase is a fibrinolytic enzyme, so heavier or longer flow is a biologically coherent effect.
- Memorial Sloan Kettering advises that nattokinase may increase bleeding risk and should be avoided by people with coagulation disorders or already on anticoagulant therapy.
- Von Willebrand disease, the most common inherited bleeding disorder, is a frequent and frequently undiagnosed cause of heavy menstrual bleeding, and it is also a clear contraindication to nattokinase. This overlap matters more than the supplement question itself.
- Some marketing promotes nattokinase for endometriosis and heavy bleeding. That is not supported by clinical evidence and runs counter to its known pharmacology.
- New or worsening heavy bleeding deserves evaluation regardless of supplements, because fibroids, polyps, thyroid dysfunction, perimenopause, and bleeding disorders are all on the differential.
This post contains affiliate links. As an Amazon Associate, NattokinaseHub earns from qualifying purchases at no extra cost to you.
Why the Mechanism Is Plausible
Menstrual bleeding is not simply blood leaving the body. It is a tightly regulated process in which clot formation and clot breakdown are balanced locally within the endometrium. Fibrinolytic activity in the uterine lining is part of why menstrual blood does not clot the way blood from a cut does, and excessive local fibrinolysis is a recognized contributor to heavy menstrual bleeding.[1] This is not a fringe idea: it is the reason tranexamic acid, an antifibrinolytic drug, is a standard prescription treatment for menorrhagia. Tranexamic acid works by inhibiting fibrinolysis.
Nattokinase does the opposite. It is a fibrinolytic enzyme, and lab and animal studies show clot-dissolving and antiplatelet activity, although in healthy young men a single dose changed clotting tests only within the normal range [2][3][4]. Taking a systemic fibrinolytic while the standard drug treatment for heavy periods is a systemic antifibrinolytic is, at minimum, a mechanistically coherent reason to expect heavier flow in some people. Several clinical guides list heavier menstrual flow as a potential side effect, and warn about combining it with prescription blood thinners, although human interaction data are lacking [5][6][7].
The measured clotting effects in healthy people have been small. A single dose in 12 healthy young men changed coagulation tests only within the normal range, and 265 healthy adults taking 2,000 FU for a median of 3 years showed no change in prothrombin time or aPTT versus placebo. None of these studies measured menstrual flow [4][7][10].
What the Evidence Actually Is
It is important to be precise here, because plausible is not the same as demonstrated. There are no clinical studies evaluating nattokinase’s effects on menstrual symptoms. What exists is a mechanism, clinical caution from supplement-safety references, and anecdotal reports. The broader bleeding-risk literature for nattokinase is itself mixed: some studies suggest increased bleeding risk while others found no significant increase, and these have mainly been conducted in animals or small human groups. So the honest summary is that this is a reasonable concern with no data behind it in either direction, and someone telling you confidently that nattokinase definitely will or definitely will not affect your cycle is going beyond what anyone knows.
Research note: A 2025 review says the risks of long-term nattokinase use, such as bleeding tendency, and its interactions with existing lipid-lowering drugs lack data support [11].
On general bleeding risk, the cautions are firmer. Memorial Sloan Kettering warns that nattokinase may increase bleeding risk and should be avoided by people with coagulation disorders or those already using anticoagulant therapy, and its reference material includes case reports of serious harm, including fatal internal bleeding in a 92-year-old woman who was taking over-the-counter nattokinase daily for atrial fibrillation; the authors presumed nattokinase contributed, but causation is not proven and she was not on an anticoagulant [8]. Combining nattokinase with warfarin or a direct oral anticoagulant may add to bleeding risk; human interaction data are lacking, and a Health Canada licence says not to use it with products that affect blood coagulation [5][9]. A conservative approach is to stop nattokinase at least one week before major surgery.
The Overlap That Matters More Than the Supplement
Here is the part worth reading twice. People with bleeding disorders such as hemophilia or von Willebrand disease should not use nattokinase. And von Willebrand disease, the most common inherited bleeding disorder, is a well-recognized and commonly undiagnosed cause of heavy menstrual bleeding. Heavy periods are often the presenting symptom, and many women carry the diagnosis for years without knowing it, because they have no comparison point for what a normal period volume is.
That creates a specific trap. A woman with undiagnosed von Willebrand disease has heavy periods, goes looking for a circulation or women’s health supplement, starts nattokinase, and is now taking a fibrinolytic enzyme while having an unrecognized contraindication to it. If your periods have always been heavy, if you bruise easily, if dental work or minor cuts bleed longer than seems normal, or if heavy bleeding runs in your family, that pattern deserves a workup before you add any supplement with blood-thinning activity. This is not a supplement question. It is a diagnosis you would want to know about regardless.
The Marketing Claim That Gets This Backward
Some supplement sources actively promote nattokinase for endometriosis and for heavy bleeding, usually via arguments about breaking down adhesions or fibrin deposits. That claim is not supported by clinical evidence, and for the heavy bleeding application specifically it runs directly counter to nattokinase’s known pharmacology. A fibrinolytic marketed as a treatment for a condition treated clinically with antifibrinolytics is a claim that should raise your guard, not lower it. Be particularly skeptical of women’s health product pages that list heavy bleeding as both a reason to take nattokinase and a possible side effect of it.
What To Do If Your Periods Got Heavier
If bleeding increased noticeably after you started nattokinase, the reasonable sequence is to stop the supplement and get evaluated rather than assuming either explanation. The timing may be coincidental. New or worsening heavy menstrual bleeding has a real differential that includes uterine fibroids, endometrial polyps, adenomyosis, thyroid dysfunction, perimenopausal hormonal shifts, and underlying bleeding disorders, and several of those benefit from being caught early. Assuming it was just the supplement risks missing something that matters. Seek prompt medical attention for soaking through a pad or tampon hourly for several consecutive hours, passing clots larger than a quarter, bleeding lasting more than seven days, or symptoms of anemia such as unusual fatigue, breathlessness, or dizziness.
Frequently Asked Questions
Can nattokinase make your period heavier?
It is mechanistically plausible, because nattokinase is fibrinolytic and menstrual flow is regulated partly by local fibrinolysis in the endometrium, but no clinical study has tested it. Some clinical guides list heavier menstrual flow as a potential side effect based on mechanism and anecdotal reports rather than trial data.
Should I stop nattokinase during my period?
There is no research establishing whether cycling off during menstruation reduces flow, so this is untested. If bleeding is heavy enough that you are considering it, the more useful step is discussing the supplement and your bleeding pattern with a clinician rather than self-managing the schedule.
Is nattokinase safe for women with heavy periods?
Women with unusually heavy periods should discuss it with a healthcare provider before supplementing. Heavy menstrual bleeding can be the presenting sign of an undiagnosed bleeding disorder such as von Willebrand disease, which is itself a contraindication to nattokinase.
Does nattokinase help endometriosis?
There is no clinical evidence supporting nattokinase for endometriosis. Marketing claims in this area are based on mechanistic speculation about fibrin and adhesions, and for anyone whose main symptom is heavy bleeding, the pharmacology points the wrong way.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. If you experience heavy or prolonged menstrual bleeding, talk to your physician. Heavy bleeding can indicate a treatable underlying condition and should be evaluated rather than self-managed with supplements.
References
- Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease. International Journal of Molecular Sciences (2017). PMID 28264497
- Ja‐Young Jang et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Laboratory Animal Research (2013). PMID 24396387
- Tetsumei Urano et al. The Profibrinolytic Enzyme Subtilisin NAT Purified fromBacillus subtilis Cleaves and Inactivates Plasminogen Activator Inhibitor Type 1. Journal of Biological Chemistry (2001). PMID 11325965
- Yuko Kurosawa et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports (2015). PMID 26109079
- Chen H et al. Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomarker insights (2018). PMID 30013308
- Muric M et al. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase-Bridging Basic Research to Clinical Findings. Biomolecules (2024). PMID 39199344
- Li X et al. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in cardiovascular medicine (2023). PMID 39076715
- Lintu Ramachandran et al. Nattokinase-Associated Hemoperitoneum in an Elderly Woman. Cureus (2021). PMID 35003944
- Health Canada Licensed Natural Health Product NPN 80089299: Nattokinase 100 mg. Health Canada (2026). source
- Hodis HN et al. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical hemorheology and microcirculation (2021). PMID 33843667
- Wei C et al. Research Progress of Nattokinase in Reducing Blood Lipid. Nutrients (2025). PMID 40507053
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
